The inhibitory effect of FOXF2 on β-catenin, c-Myc, CyclinDl, MMP9, and Lgr5 will provide an important theoretical basis for the diagnosis and targetted therapy of cervical cancer. This evidence concerns the gene LGR5 and cervical carcinoma.